Side-by-side comparison of AI visibility scores, market position, and capabilities
Bogota multi-exchange stock trading app for Colombian, Peruvian, and Chilean markets; $9M YC-backed with Bancolombia investment at $6.2M revenue competing to democratize Andean equity investing.
trii is a Bogota-based mobile investment platform enabling retail investors in Latin America to trade stocks across the Colombian (BVC), Peruvian (BVL), and Chilean (Santiago) stock exchanges directly from their smartphones — providing the brokerage infrastructure that democratizes equity investing across three Andean markets from a single app. Founded in 2019 and backed by Y Combinator with $9 million raised including a $3 million strategic investment from Bancolombia in 2022, trii generated $6.2 million in revenue in 2024.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.